Markets
Tech
Media
Success
Video
Markets
Premarkets
Dow
After-Hours
Market Movers
Fear & Greed
World Markets
Investing
Markets Now
Before the Bell
Leading Indicator
Global Energy Challenge
Economy
Energy
Tech
Innovate
Gadget
Mission: Ahead
Upstarts
Business Evolved
Work Transformed
Innovative Cities
Unhackable
Media
Reliable Sources
Success
Boss Files
Fresh Money
Cars
Homes
Biz + Leisure
Center Piece
Perspectives
Video
International
Switzerland
India
Davos
Passion to Portfolio
On: Germany
More
Newsletters
About Us
Accessibility and CC
U.S.
World
Politics
Business
Opinion
Health
Entertainment
Tech
Style
Travel
Sports
Video
Shop
VR
More...
Follow CNN Business
Do Not Sell
Moderna Inc
(NASDAQ:MRNA)
173.21
Delayed Data
As of Feb 03
-3.10
/
-1.76%
Today’s Change
115.03
Today
|||
52-Week Range
217.25
-3.57%
Year-to-Date
Quote
Profile
News
Charts
Forecasts
Financials
Shareholders
Competitors
Latest MRNA News
|
Press Releases
Top 5 4th Quarter Trades of Lipe & Dalton
Feb 03 / GuruFocus News - Paid Partner Content
The Zacks Analyst Blog Highlights Pfizer/BioNTech, Moderna and Novavax
Jan 30 / Zacks.com - Paid Partner Content
3 No-Brainer Growth Stocks to Buy in 2023
Feb 03 / MotleyFool.com - Paid Partner Content
2 Struggling Stocks to Buy Hand Over Fist in 2023 and 1 to Avoid Like the Plague
Jan 29 / MotleyFool.com - Paid Partner Content
Is Moderna Stock a Buy Now?
Feb 03 / MotleyFool.com - Paid Partner Content
Novavax (NVAX) COVID Jab Aids Growth, Overdependence a Challenge (revised)
Jan 27 / Zacks.com - Paid Partner Content
Moderna (MRNA) Stock Sinks As Market Gains: What You Should Know
Feb 01 / Zacks.com - Paid Partner Content
FDA Panel Endorses Simplification of COVID-19 Vaccine Strategy
Jan 27 / Zacks.com - Paid Partner Content
1 Reason to Buy Novavax in 2023 and 2 Reasons to Sell
Feb 01 / MotleyFool.com - Paid Partner Content
Moderna (MRNA) Gains But Lags Market: What You Should Know
Jan 26 / Zacks.com - Paid Partner Content
Top 5 4th Quarter Trades of REIK & CO., LLC
Jan 31 / GuruFocus News - Paid Partner Content
2 Top Biotech Stocks to Buy for the Long Haul
Jan 26 / MotleyFool.com - Paid Partner Content
This Discount Growth Stock Is a Once-in-a-Decade Buying Opportunity Right Now
Jan 31 / MotleyFool.com - Paid Partner Content
Novavax (NVAX) COVID Jab Aids Growth, Overdependence A Woe
Jan 26 / Zacks.com - Paid Partner Content
Moderna (MRNA) RSV Jab For Older Adults Gets FDA Breakthrough Tag
Jan 31 / Zacks.com - Paid Partner Content
Could This RSV News Make Moderna a Hot Buy Again?
Jan 25 / MotleyFool.com - Paid Partner Content
The Covid sales boom is over for Pfizer
Jan 31 / CNN.com
Moderna, Inc. (MRNA) is Attracting Investor Attention: Here is What You Should Know
Jan 25 / Zacks.com - Paid Partner Content